New Research Links Autism and Alzheimer's Through Shared Biology

Anavex Life Sciences recently highlighted scientific findings suggesting a shared biological mechanism between autism spectrum disorder (ASD) and Alzheimer's disease. According to the company, both conditions may involve impaired autophagy (the body's cellular 'cleanup' process) and synaptic dysfunction.

Why This Matters for Autism Families

This research could open new doors for autism therapies. Anavex's drug candidate blarcamesine (ANAVEX® 2-73), originally studied for Alzheimer's, targets these shared mechanisms and is taken orally. The company plans to advance it into clinical trials for conditions with these overlapping biological features.

Key Takeaways

1. Shared pathways: Autism and Alzheimer's may involve similar cellular processes, which could lead to repurposing treatments.
2. Hope for future options: Blarcamesine's mechanism aligns with these findings, though more research is needed.
3. Watch for updates: Anavex intends to pursue clinical studies—families can follow developments.

While this research is in early stages, it underscores the importance of understanding autism's biological basis. For families, it's a reminder to consult trusted medical professionals about emerging science.

Source: Anavex Life Sciences (April 14, 2026)